Editorials

Drug Importation is Fraught with Peril

August 23, 2018

As a licensed pharmacist, I’m all too familiar with patients’ difficulties getting medications they need and their physician has prescribed. As baby boomers age, pharmacists see more patients at our counters unable to obtain needed treatments for heart disease, high blood pressure, diabetes, and other chronic illnesses. This issue is now being acknowledged and a healthy debate has begun over possible solutions. But one idea policymakers shouldn’t pursue is opening up our country’s secure drug supply to medicines coming from outside our borders.

Drug Importation Isn’t Safe and It Doesn’t Make Economic Sense, Says PSM President

May 31, 2018

In this May 31, 2018 editorial for The Daily Caller, pharmacoeconomic expert Dr. Marv Shepherd explains the concrete reasons why the importation of drugs from other countries as a means to lowering prices in the U.S. is both unsafe and economically unsound.

STAT black market importation policy recommendation based in rhetoric, not facts

June 14, 2017

The most recent editorial in Stat advocating black market drug importation under the guise of “ordering prescription drugs abroad” overlooks many safety dangers. The most important oversight is in the characterization of the cost of medications. Over 80% of all medications dispensed in the U.S. are dispensed as generic, and generics as a whole are cheaper in America than Canada. But importation proponents often ignore generics and cite brand name price comparisons to justify their flawed policies. The Stat editorial falls into the same trap.  It cites a price list from PharmacyChecker.com comparing prices for medications in the US versus…

How to Stay Safe as a Patient

March 30, 2012

Patients are growing concerned about reports of counterfeit drugs being provided by doctors. Patients can protect themselves by asking their physicians questions about the origins of medicines they receive in their doctor’s office.

Read more about what patients can do to stay safe.

“Safe” Country Focus: United Kingdom

November 13, 2009

As my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.